Alvogen Malta (Out-Licensing) Ltd./Amol Ltd. Saneca Pharmaceuticals a. s.

This medicine is used in adults to reduce the risk of a subsequent heart attack or death due to cardiovascular disease (following acute coronary syndrome). It is also used to reduce the risk of blood clots in people with coronary artery disease or peripheral artery disease.

Dosage form: tablets, film-coated

ATC: B01AF01

The medicine is used in adults to prevent the formation of blood clots in the veins after hip or knee replacement surgery, to treat deep vein thrombosis and pulmonary embolism, and to prevent their recurrence.

Dosage form: tablets, film-coated

ATC: B01AF01

The medicine is used in adults to prevent strokes and other blood clots (e.g., in atrial fibrillation) and to treat and prevent blood clots in the leg veins and pulmonary vessels. In children and adolescents (weighing more than 30 kg), it is used to treat blood clots after initial injectable treatment.

Dosage form: tablets, film-coated

ATC: B01AF01